← All organizations

Wellstat Therapeutics

For profitContributed to NMEWebsite ↗

Also known as: WELLSTAT THERAP | Wellstat Therapeutics Corporation

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

First marketed drug

First NDA

Last known activity

Apr 1, 2014

Defunct as of Jan 31, 2020

Timeline

1980s

Jul 2, 1985
Wellstat Therapeutics— Founded

2010s

Sep 4, 2015
uridine— NDA Secondary Org
Dec 11, 2015
uridine— NDA Organization

2020s

Jan 31, 2020
Wellstat Therapeutics— Defunct

Drugs by trial phase (8 distinct, 6 trials)

Phase 3 (3 own, 0 via acquisition)

Phase 2 (3 own, 0 via acquisition)

Phase 1 (2 own, 0 via acquisition)

Indications

Approved for

Studied for

Marketed drugs (1)

uridine

Recent trials (8)

NCT02110147Lead sponsorPhase 2Apr 1, 2014
NCT02110147Study directorPhase 2Apr 1, 2014
NCT01432301Lead sponsorN/ASep 8, 2011
NCT00110864Lead sponsorPhase 2May 1, 2005
NCT00110851Lead sponsorPhase 2Apr 1, 2005
NCT00044785Lead sponsorPhase 1Aug 1, 2002
NCT00024427Study chairPhase 3Feb 1, 2001
NCT00024427Lead sponsorPhase 3Feb 1, 2001

Details

Founded: Gaithersburg, MD, US Jul 2, 1985
First NDA: Dec 11, 2015
Last known activity: Apr 1, 2014

Designations held

Orphan drug
Priority review
Breakthrough therapy